- Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients. Ansell, S.M., Geyer, S.M., Maurer, M.J., Kurtin, P.J., Micallef, I.N., Stella, P., Etzell, P., Novak, A.J., Erlichman, C., Witzig, T.E. Clin. Cancer Res. (2006)